Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of rectal tacrolimus
NL-OMON28377Active, not recruiting
- Sponsor
- National Poisons Information Centre
- Start
- Oct 2015
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus in transplantation, sponsored by National Poisons Information Centre. Primary endpoint: Bioavailability of rectally administered tacrolimus. Started Oct 2015; status: active, not recruiting.
02
Drugs
tacrolimus
03
Conditions
transplantation
Beyond the preview
Go deeper on NL-OMON28377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28377.